* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Y.S.P. Southeast Asia Holding Bhd FCF Margin % Chart
XKLS:7178 vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Y.S.P. Southeast Asia Holding Bhd FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a FCF Margin % of 5.67% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. This is 45% below median its historical median of 10.36. According to the industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #170 out of 955 companies in the Drug Manufacturers industry, placing it in the top 17.8%.
Is Y.S.P. Southeast Asia Holding Bhd's FCF Margin % too high?
Y.S.P. Southeast Asia Holding Bhd's current FCF Margin % of 5.67% is 45% below median its 10-year median of 10.36. The Drug Manufacturers industry median FCF Margin % is 2.51. Y.S.P. Southeast Asia Holding Bhd's value of 5.67% is 125.9% above this industry median. Based on the distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #170 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #170 out of 955 companies for FCF Margin %. This places Y.S.P. Southeast Asia Holding Bhd in the top 18% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Y.S.P. Southeast Asia Holding Bhd's value of 5.67% is 125.9% above this benchmark. While the company's 10-year median is 10.36 vs. the industry median of 2.51, Y.S.P. Southeast Asia Holding Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Y.S.P. Southeast Asia Holding Bhd's current FCF Margin % of 5.67% is 125.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current FCF Margin % is 5.67%, which is 45% below median its own 10-year median of 10.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.40, compared to a current price of RM2.04 — trading 15% below its estimated fair value. The current FCF Margin % is 5.67%, which is 45% below median its 10-year median of 10.36 and 125.9% above the Drug Manufacturers industry median of 2.51. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current FCF Margin % is 5.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued.
The current stock price of RM2.04 is trading 15% below its estimated GF Value™ of RM2.40.
GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7178:
FCF Margin %: 5.67% (45% below median its 10-year median of 10.36)
GF Value™: RM2.40 vs. price of RM2.04 (15% below fair value)
Industry Position: 125.9% above the Drug Manufacturers median (#170 of 955)
No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Y.S.P. Southeast Asia Holding Bhd Business Description
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
82GF Score
Get the complete analysis for XKLS:7178
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7178 has been successfully added to your 
